Mengqing Xiao Selected Research

Mengqing Xiao Research Topics

Disease

16	Neoplasms (Cancer) 12/2022 - 01/2017
7	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2017
2	Nasopharyngeal Carcinoma 06/2023 - 01/2020
2	Carcinogenesis 12/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2019
2	Adenocarcinoma of Lung 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2017 - 01/2017
1	Cardiotoxicity 11/2023
1	Fibrosis (Cirrhosis) 11/2023
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022
1	Hepatitis 01/2022
1	Enteritis 07/2021
1	Mucositis 07/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2017
1	Liver Neoplasms (Liver Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 01/2021 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 01/2020
3	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
2	ran-binding protein 2IBA 02/2024 - 07/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	Competitive Endogenous RNAIBA 01/2021 - 11/2020
2	Ligases (Synthetase)IBA 01/2020 - 01/2020
2	UbiquitinIBA 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2017
2	Cardiolipins (Cardiolipin)IBA 01/2019 - 01/2017
2	LipidsIBA 10/2017 - 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023
1	Circular RNAIBA 06/2023
1	Protein Isoforms (Isoforms)IBA 12/2022
1	Serine (L-Serine)FDA Link 12/2022
1	Arginine (L-Arginine)FDA Link 12/2022
1	RNA Splicing FactorsIBA 12/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2022
1	purineIBA 01/2022
1	AlbuminsIBA 07/2021
1	ElementsIBA 07/2021
1	SeleniumIBA 07/2021
1	Serpentine Asbestos (Chrysotile)IBA 06/2021
1	AntigensIBA 06/2021
1	N-methyladenosineIBA 01/2021
1	6-methyladenineIBA 01/2021
1	LigandsIBA 01/2021
1	Lactate Dehydrogenase 5IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2021
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	CholesterolIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	ClayIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	StaurosporineIBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
3	Immunotherapy 10/2021 - 01/2020
1	Fecal Microbiota Transplantation 07/2021
1	Drug Therapy (Chemotherapy) 07/2021
1	Radiotherapy 01/2021